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The British government has
launched a new public debate on
genetically modified (GM) crops as
the three-year ban on growing
such crops commercially is due to
finish next year. But field-scale
trials of oilseed rape, which have
been carried out in the UK during
this time, have fuelled opponents
of the new technology and studies
elsewhere have raised further
questions many believe need to
be addressed before moving
forward. There has been a
moratorium on the approval of
new GM crops across the
European Union since 1998 due to
public anxiety about potential
risks.
Launching the new debate,
Michael Meacher, the environment
minister, said that the real position
might be different. ‘The public is
not overwhelmingly pro- or anti-
GM, as demonstrated by research
on attitudes to GM in Europe. This
found that there is a major gap
between actual public attitudes,
and perceptions of public
attitudes amongst policymakers.’
But crucially that research
found that a powerful factor in
determining public attitudes to
GM is the ‘behaviour of
institutions responsible for
development and regulation of
technological innovations and
risks’, he said.
Britain’s efforts to take make a
fresh attempt to gauge public
opinion comes at a time of
increasing tension. Ministers have
said that they are coming under
intense lobbying from the US and
the biotech industry to accept GM
products. Such crops have been
planted across large areas of US
farmland and in other countries
such as China. Elliot Morley, a
rural affairs minister, told a radio
programme: ‘There is enormous
international pressure to allow GM
crops and seeds in this country
from the biotech companies. They
are going through national
governments and the World Trade
Organisation and pressuring the
EU.’ And while consulting the
public in the new survey, Meacher
has said that Britain would not be
‘bounced’ into accepting GM
crops.
The biotech companies now
know that next spring’s planting
season has been missed and the
next window of opportunity is
spring 2004. This may be the
reason why Morley floated the
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Grains of contention: Europe remains a battleground between the supporters and opponents of genetically modified crops, such
as the corn shown here. Britain is now planning new public consultation. (Photo: Science Photo Library.)
Biotech companies are now pressing Europe to give the go-ahead for
commercial planting of genetically modified crops but opposition is still
running high. Britain is now hoping to find out what the public really
thinks. Nigel Williams reports. 
possibility of extending the
moratorium on commercial
growing of GM crops in Britain,
but such a move would likely
deepen the rift between
Washington and Brussels.The
decision on whether commercial
planting is allowed will ultimately
be made at the European level,
and resistance among some
countries, including France and
Greece, is particularly fierce. 
Already Monsanto, one of the
US’s biggest corporations
promoting (GM) products,
conceded last month that it
expects it will take another three
years before winning approval for
their sale in Europe.
And while the oilseed rape trials
have provided a lot of valuable
information about the potential
environmental impact of such
crops, they have also given
opponents plenty of ammunition.
The trials are part of a deal
between the government and
industry aimed at trying to
reassure the public. 
The recent revelation that
Aventis Crop Science, the
company running the oilseed rape
trials, had been planting seed
contaminated with varieties
containing antibiotic-resistance
genes over three years without
anyone realising has raised fears
about mechanisms for monitoring
GM technology. 
Aventis may be prosecuted for
planting the rogue varieties but
the company’s spokesperson,
Julian Little, said: ‘As soon as we
realised there was a problem we
told the government. It is
unfortunate, but the crops are
very similar and the difference
was hard to detect. GM remains
one of the world’s most tightly
regulated industries and we are
confident the technology is safe.’
He said the company was also
confident that the results of the
trials would show that biodiversity
in the British countryside was not
affected or would improve with
biotechnology. It was also
possible for conventional and
organic farming to coexist with
GM crops. ‘The technology still
has huge development potential,’
he said.
That revelation was followed by
the discovery that stubble of
harvested GM oilseed rape had
resprouted and had begun to
flower again in the autumn
following one trial. The GM
inspectorate found the reflowering
rape at four sites in central and
northern England. Aventis were
bound by strict conditions to stop
the rape flowering again, but
these only covered the danger of
flowers appearing on new plants
growing from seeds from the
harvested crop. The inspectorate
concluded Aventis had not
breached its conditions.
While these may be seen as
technical issues arising from the
very strict conditions imposed on
the trials, other studies have raised
some of the potential biological
problems facing GM crops. Genes
can be transferred from GM plants
to native, wild-growing relatives
with the potential that these may
become major weeds of the
commercial crop. Henk van Dijk
and colleagues from the University
of Lille in France studied sugar
beet and showed GM varieties
swapped genes with weeds,
sometimes to the detriment of the
GM plants. 
Another recent study by a team
led by Allison Snow at Ohio State
University, looked at sunflowers.
They found that a wild variety,
considered a weed by many
farmers in the US, becomes
hardier and produces up to 50 per
cent more seed if crossed with a
GM sunflower resistant to a seed-
eating moth larvae. Pioneer
Hi-Bred of Iowa, which developed
the GM sunflower, said it had no
plans to sell the strain
commercially.
Findings such as these highlight
many issues emerging in GM
technology and the place in which
a GM crop is grown can also be
very important. For example,
cross-contamination of genes
might be less of a problem in
countries where crops have been
introduced from elsewhere, such
as soya grown in the US, where
no native relatives exist. But in
Europe, where native weed
species of both oilseed rape and
beet exist, the risk is potentially
significant.
The British government’s
Agriculture and Environment
Biotechnology Commission has
now been given the task of
establishing the plan for the public
consultation. An independent
steering group is being set up to
lead the debate. It is expected
that public meetings will be held
and that the environment
secretary, Margaret Beckett, will
tour the country to help test
opinion. The prime minister has
agreed a budget of £250,000 for
the exercise.
The government has announced
two other studies. Beckett said
that she has instructed the
government’s performance and
innovation unit to examine the
costs and benefits of GM crops
after claims that the technology
offers farmers little financial
incentive to plant them. ‘I believe
it is crucial to have an informed
and open debate about these
issues,’ she said.
The second study, led by the
chief scientific adviser, will review
the scientific issues relating to GM
technology.
But there are signs that
enthusiasts for GM technology
face a tough task. During the
three years of the trials some
attitudes have hardened.
Supermarkets in Britain were at
first receptive to products made
from GM crops. When they first
stocked tomato paste made from
GM tomatoes, and clearly labelled
it as such, it sold well. But now
supermarkets have withdrawn GM
products from their shelves and
insisted that their entire supply
chain, including animal feed, is
GM-free. Manufactures and even
restaurants find ‘GM-free’ can be
a selling point. 
Also, the actions of Greenpeace
and other individuals opposed to
GM crops who have destroyed
trial plants around the country
have attracted some public
support and relatively little
condemnation as acts of
vandalism.
GM technology may presently
be a casualty of wider concerns
about food production following
Britain’s devastating mad-cow
disease and a major foot and
mouth disease epidemic. The
results of the new consultation
may help give a truer view of what
the real public concerns about
GM crops might be.
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